Improvement in Cognitive Processing Speed With Ofatumumab in Patients With Relapsing Multiple Sclerosis

被引：1
|
作者：
Benedict, Ralph
Penner, Iris Katharina
Cutter, Gary
Kappos, Ludwig
Coyle, Patricia
Piani-Meier, Daniela
Azmon, Amin
Boer, Ibolya
Su, Wendy
Cohen, Jeffrey
机构：
来源：
NEUROLOGY | 2023年 / 100卷 / 17期
关键词：
D O I：
10.1212/WNL.0000000000203201
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6-3.005
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] Improvement in Cognitive Processing Speed with Ofatumumab in Patients with Relapsing Multiple Sclerosis
    Benedict, R. H. B.
    Penner, I. -K.
    Cutter, G.
    Kappos, L.
    Coyle, P. K.
    Piani-Meier, D.
    Azmon, A.
    Boer, I.
    Su, W.
    Cohen, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 149 - 149
  • [2] Ofatumumab for relapsing forms of multiple sclerosis
    Gajofatto, Alberto
    Orlandi, Riccardo
    DRUGS OF TODAY, 2022, 58 (01) : 9 - 21
  • [3] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [4] LONG-TERM EFFICACY OF OFATUMUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Hauser, Stephen
    Fox, Edward
    Aungst, Angela
    Su, Wendy
    Zielman, Ronald
    Das Gupta, Ayan
    Stoneman, Dee
    Robertson, Derrick
    Cohen, Jeffrey
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [5] Longer-term Efficacy of Ofatumumab in Patients with Relapsing Multiple Sclerosis
    Kappos, L.
    Fox, E.
    Aungst, A.
    Su, W.
    Zielman, R.
    Gupta, A.
    Xi, J.
    Stoneman, D.
    Robertson, D.
    Cohen, J.
    Hauser, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 284 - 285
  • [6] Longer-term Safety of Ofatumumab in Patients With Relapsing Multiple Sclerosis
    Sacca, F.
    Hauser, S.
    Cross, A.
    Winthrop, K.
    Wiendl, H.
    Nicholas, J.
    Meuth, S.
    Giacomini, P.
    Zielman, R.
    Hu, X.
    Gupta, A.
    Sullivan, R.
    DeLasHeras, V.
    Su, W.
    Kappos, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 152 - 152
  • [7] LONG-TERM SAFETY OF OFATUMUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS
    Hauser, Stephen
    Cross, Anne
    Winthrop, Kevin
    Wiendl, Heniz
    Nicholas, Jacqueline
    Meuth, Sven
    Giacomini, Paul
    Sacca, Francesco
    Su, Wendy
    Kappos, Ludwig
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):
  • [8] Cognitive aging in patients with multiple sclerosis: an analysis of processing speed
    Boding, Angela M.
    Denney, Doughlas R.
    Lynch, Sharon G.
    MULTIPLE SCLEROSIS, 2008, 14 : S255 - S255
  • [9] Correction to: Ofatumumab: A Review in Relapsing Forms of Multiple Sclerosis
    Connie Kang
    Hannah A. Blair
    Drugs, 2022, 82 (1) : 63 - 63
  • [10] Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis
    Huixin Yu
    Gordon Graham
    Olivier J. David
    Joseph M. Kahn
    Marina Savelieva
    Etienne Pigeolet
    Ayan Das Gupta
    Ratnakar Pingili
    Roman Willi
    Krishnan Ramanathan
    Bernd C. Kieseier
    Dieter A. Häring
    Morten Bagger
    Per Soelberg Sørensen
    CNS Drugs, 2022, 36 : 283 - 300
12345